8-K: THC Therapeutics Changes Auditors After SEC Revokes Previous Firm's Registration

Sentiment:

Current Report


THC Therapeutics has dismissed its auditor, Gries & Associates, after the SEC revoked their registration, and has engaged Green Growth CPAs as their new independent accountant.

Worse than expectedThe revocation of the auditor's registration by the SEC is a negative event.The going concern qualification in the 2023 financial statements indicates potential financial instability.

Summary

  • THC Therapeutics received notification from the SEC on March 8, 2024, that the Public Accounting Oversight Board had revoked the registration of their auditor, Gries & Associates, LLC.
  • The company's Board of Directors approved the dismissal of Gries & Associates on the same day.
  • Gries & Associates' reports on the company's financial statements for the past two years did not contain any adverse opinions or disclaimers, except for a going concern qualification in the 2023 financial statements.
  • There were no disagreements between THC Therapeutics and Gries & Associates on accounting principles, financial statement disclosure, or auditing scope.
  • THC Therapeutics has engaged Green Growth CPAs as their new independent accountant, effective immediately on March 8, 2024.
  • The company did not consult with Green Growth CPAs on accounting principles or audit opinions prior to their engagement.

Sentiment

Score: 3

Explanation: The document highlights a significant negative event with the revocation of the auditor's registration and a going concern qualification, indicating potential financial instability and raising concerns about the company's financial health.

Positives

  • The company acted swiftly to replace their auditor after the SEC revocation.
  • There were no disagreements with the previous auditor on accounting principles or practices.

Negatives

  • The company's previous auditor had their registration revoked by the Public Accounting Oversight Board.
  • The 2023 financial statements contained a going concern qualification.

Risks

  • The revocation of the previous auditor's registration could raise concerns about the company's past financial reporting.
  • The going concern qualification in the 2023 financial statements indicates potential financial instability.

Future Outlook

The company will file an amendment to this report to include a letter from Gries & Associates if they respond to the company's request.

Management Comments

  • The Board of Directors approved the dismissal of Gries & Associates and the engagement of Green Growth CPAs.
  • The company requested a letter from Gries & Associates regarding their agreement with the disclosures in the 8-K filing.

Industry Context

Changes in auditors are not uncommon, but the revocation of an auditor's registration by the SEC is a significant event that could raise concerns among investors and stakeholders.

Comparison to Industry Standards

  • The dismissal of an auditor due to regulatory issues is unusual, as most auditor changes are due to disagreements or the end of a contract.
  • Companies typically engage a new auditor after a thorough selection process, but in this case, the change was driven by the SEC's action.
  • The going concern qualification in the 2023 financial statements is a red flag, as it indicates that the company's ability to continue as a going concern is in question.

Stakeholder Impact

  • Shareholders may be concerned about the change in auditors and the going concern qualification.
  • Creditors may be more cautious about extending credit to the company.

Next Steps

  • The company will file an amendment to this report to include a letter from Gries & Associates if they respond to the company's request.

Key Dates

DateDescription
March 8, 2024SEC informed THC Therapeutics of the revocation of Gries & Associates' registration, Gries was dismissed, and Green Growth CPAs was engaged.
March 14, 2024Date of the 8-K filing.

Keywords

auditor, accounting, SEC, Gries & Associates, Green Growth CPAs, financial statements, Public Accounting Oversight Board, going concern

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.